-
Express Scripts (ESRX) PT Lowered to $91 at RBC Capital
-
RBC Capital Upgrades Express Scripts (ESRX) to Outperform
-
RBC Capital Starts Express Scripts (ESRX) at Sector Perform
-
RBC Comments on Weakness in Gilead Sciences (GILD)
-
Gilead Sciences (GILD) to Get Relief from CVS (CVS) Deal, Says RBC
-
Gilead (GILD) Could Unleash Massive Accelerated Repurchase, Suggests RBC Capital
-
Gilead (GILD) Tanks; Analyst Comments on Express Scripts (ESRX) Viekira Pak Announcement (ABBV)
-
Notable Analyst Rating Changes 06/02: (MHR) (TRIP) (SNV) Upgraded; (ESRX) (Z) (XLNX) Downgraded
-
Notable Analyst Rating Changes 03/05: (P) (TRMB) (DST) Upgraded; (DDS) (SPLS) (PEI) Downgraded
-
RBC Starts Express Scripts (ESRX), Medco (MHS) at Outperform, CVS (CVS) at Sector Perform
-
David Moenning's Daily State of the Markets: 3/13
-
Morning Movers 10/17: Google (GOOG) Up On Results; SunPower (SPWRA) Lower on Downgrades

